These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 12466752)
1. Update on hepatitis B treatment. Firpi RJ; Martin P MedGenMed; 2002 Sep; 4(3):9. PubMed ID: 12466752 [No Abstract] [Full Text] [Related]
2. Antiviral therapy of chronic hepatitis B. Zoulim F Antiviral Res; 2006 Sep; 71(2-3):206-15. PubMed ID: 16716414 [TBL] [Abstract][Full Text] [Related]
3. Antiviral therapy for chronic hepatitis B: are we doing any good to patients? Wong VW; Sung JJ J Antimicrob Chemother; 2009 Aug; 64(2):223-6. PubMed ID: 19468026 [TBL] [Abstract][Full Text] [Related]
4. [Managing resistance to analogue antiviral drugs in a chronic compensated hepatitis B patient]. Bronowicki JP; Barraud H; Couzigou P Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S17-9. PubMed ID: 17075490 [No Abstract] [Full Text] [Related]
5. A call for attention and trials on hepatitis B e antigen-negative, alanine aminotransferase-normal chronic hepatitis B virus infection. Zhao H; Miao R Hepatology; 2009 Aug; 50(2):658; author reply 658-9. PubMed ID: 19585650 [No Abstract] [Full Text] [Related]
6. HBV Chronic hepatitis during chemotherapy - an immune controlled disease. Caruntu FA; Gheorghita V J Gastrointestin Liver Dis; 2008 Dec; 17(4):445-9. PubMed ID: 19104707 [No Abstract] [Full Text] [Related]
7. Chronic hepatitis B: back to the future with HBsAg. Moucari R; Lada O; Marcellin P Expert Rev Anti Infect Ther; 2009 Aug; 7(6):633-6. PubMed ID: 19681689 [No Abstract] [Full Text] [Related]
8. Current therapy with nucleoside/nucleotide analogs for patients with chronic hepatitis B. Xu XW; Chen YG Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):350-9. PubMed ID: 16911930 [TBL] [Abstract][Full Text] [Related]
9. [Clinical consequences of resistance to analogue antiviral drugs in the treatment of chronic hepatitis B]. Cadranel JF Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S12-6. PubMed ID: 17075489 [No Abstract] [Full Text] [Related]
10. Treatment of chronic hepatitis B virus infection - Dutch national guidelines. Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL; Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260 [TBL] [Abstract][Full Text] [Related]
11. Sequential combination therapy for chronic hepatitis B: more challenges to be tackled. Tseng TC; Liu CJ; Kao JH Am J Gastroenterol; 2007 Jul; 102(7):1544; author reply 1545. PubMed ID: 17593169 [No Abstract] [Full Text] [Related]
12. Entecavir for chronic hepatitis B: a review. Palumbo E Ther Drug Monit; 2008 Feb; 30(1):1-4. PubMed ID: 18223455 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of chronic hepatitis B]. Mauss S MMW Fortschr Med; 2008 Apr; 150 Spec No 1():48-51. PubMed ID: 19031564 [No Abstract] [Full Text] [Related]
14. [Therapeutic aspects of human immunodeficiency virus, hepatitis B and C coinfection]. Bani-Sadr F Gastroenterol Clin Biol; 2003 May; 27(5):528-33. PubMed ID: 12843917 [No Abstract] [Full Text] [Related]
15. [Modern strategy in the treatment of chronic hepatitis B: progress and prospects]. Isakov VA Eksp Klin Gastroenterol; 2007; (2):107-12. PubMed ID: 17539354 [No Abstract] [Full Text] [Related]
16. Treatment of chronic hepatitis B with a combination of acyclovir and alpha-lymphoblastoid interferon. Schalm SW J Chemother; 1989 Jul; 1(4 Suppl):1112-4. PubMed ID: 16312795 [No Abstract] [Full Text] [Related]
17. Interferon treatment of anti-HBe positive and HBV-DNA positive chronic hepatitis type B. Alberti A; Fattovich G; Pontisso P; Brollo L; Belussi F; Ruol A J Chemother; 1989 Jul; 1(4 Suppl):1089-91. PubMed ID: 16312784 [No Abstract] [Full Text] [Related]
18. Entecavir: a potent antiviral with minimal long-term resistance in nucleoside-naive chronic hepatitis B patients. Cheng PN; Chang TT Expert Rev Anti Infect Ther; 2008 Oct; 6(5):569-79. PubMed ID: 18847396 [TBL] [Abstract][Full Text] [Related]
19. [Therapy of chronic hepatitis B. Tenofovir--first choice in current EASL guidelines]. MMW Fortschr Med; 2009 May; 151(22):38-9. PubMed ID: 19526965 [No Abstract] [Full Text] [Related]
20. [Managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B]. Marcellin P; Lada O Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S5-8. PubMed ID: 17075487 [No Abstract] [Full Text] [Related] [Next] [New Search]